UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Jun. 30, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 608.1	$ 681.8
Short-term investments	97.9	50.0
Accounts receivable, net	337.0	335.3
Inventories	730.2	692.3
Other current assets	195.0	165.6
Total current assets	1,968.2	1,925.0
Property, plant and equipment, net	398.0	395.5
Goodwill	314.9	320.4
Intangible assets, net	205.9	229.1
Other long-term assets	200.0	179.0
Total assets	3,087.0	3,049.0
Current liabilities:
Current portion of long-term debt	108.2	2.2
Accounts payable	142.6	134.6
Customer advances	192.9	189.2
Other current liabilities	510.9	465.9
Total current liabilities	954.6	791.9
Long-term debt	721.1	842.3
Other long-term liabilities	395.6	440.5
Commitments and contingencies (Note 14)
Redeemable noncontrolling interest	0.3	0.0
Shareholders' equity:
Preferred stock, $0.01 par value 5,000,000 shares authorized, none issued or outstanding	0.0	0.0
Common stock, $0.01 par value 260,000,000 shares authorized, 174,199,306 and 174,045,610 shares issued and 151,054,472 and 151,987,081 shares outstanding at June 30, 2021 and December 31, 2020, respectively	1.7	1.7
Treasury stock, at cost, 23,144,834 and 22,058,529 shares at June 30, 2021 and December 31, 2020, respectively	(738.1)	(667.0)
Accumulated other comprehensive loss	4.3	3.7
Other shareholders' equity	1,734.1	1,622.8
Total shareholders' equity attributable to Bruker Corporation	1,002.0	961.2
Noncontrolling interest in consolidated subsidiaries	13.4	13.1
Total shareholders' equity	1,015.4	974.3
Total liabilities, redeemable noncontrolling interest and shareholders' equity	$ 3,087.0	$ 3,049.0